Patent details

Basic Information

Publication number:

EP2598124

PCT Application Number:

EP2011062634

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117486043

PCT Publication Number:

WO2012013595

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THREE-PHASE CONTROLLED-RELEASE TABLET COMPRISING MELATONIN AND PROCESS OF PREPARATION

French Title of Invention:

COMPRIMÉ À LIBÉRATION CONTRÔLÉE À TROIS PHASES COMPRENANT DE LA MÉLATONINE ET PROCÉDÉ DE PRÉPARATION

German Title of Invention:

DREIPHASIGE RETARD-TABLETTE MIT MELATONIN UND HERSTELLUNGSVERFAHREN

SPC Number:

Dates

Filing date:

22/07/2011

Grant date:

04/04/2018

EP Publication Date:

05/06/2013

PCT Publication Date:

02/02/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/04/2018

EP B1 Publication Date:

04/04/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/07/2018

Expiration date:

22/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/03/2018

 

 

Name:

Ambros Pharma S.r.l.

Address:

Via Larga 2, 20122 Milano, Italy (IT)

Inventor

Name:

STANKOV, Bojidar Mihaylov

Address:

Italy (IT)

Priority

Priority Number:

MI20101374

Priority Date:

26/07/2010

Priority Country:

Italy (IT)

Classification

IPC classification:

A61K 9/20; A61K 9/24; A61K 31/404; A61K 31/4045; A61P 25/00;

Publication

European Patent Bulletin

Issue number:

201814

Publication date:

04/04/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/11/2018	Outgoing Correspondence	1